Home › Funds › Harvey Partners, LLC › BCPC

Harvey Partners, LLC position in BCPC

BALCHEM CORP · Industrials

Harvey Partners, LLC reported holding 136,057 shares of BCPC (BALCHEM CORP) in its Q2 2026 13F filing — a position valued at US$23.0M, representing 1.57% of its reported portfolio and ranking #29 among its reported holdings. Harvey Partners, LLC has disclosed BCPC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)136.06K sh
Reported value held$22.99M
Portfolio Weight1.57%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Harvey Partners, LLC's BCPC position evolved

Harvey Partners, LLC first disclosed a stake in BCPC in Q4 2025 at 116,000 shares (US$17.8M). The position peaked in Q2 2026 at 136,057 shares, worth US$23.0M. Across 3 filings, Harvey Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 136,057 shares valued at US$23.0M — an increase of 21,257 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 116.00K $17.79M New
Q1 2026 114.80K $19.46M Reduce
Q2 2026 136.06K $22.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCPC and 13F data

BCPC (BALCHEM CORP) is a Industrials company. 31 other funds we track also report a position in BCPC — the largest reported positions include Conestoga Capital Advisors, LLC (US$183.8M), GENEVA CAPITAL MANAGEMENT LLC (US$115.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCPC

All BCPC fund holders →

FAQ

How long has Harvey Partners, LLC held BCPC?

Harvey Partners, LLC has disclosed BCPC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Harvey Partners, LLC's current position in BCPC?

As of Q2 2026, Harvey Partners, LLC holds 136.06K shares of BCPC (BALCHEM CORP), valued at $22.99M, representing 1.57% of its reported portfolio and ranking #29.

Has Harvey Partners, LLC been buying or selling BCPC?

In the latest 13F filing (Q2 2026), Harvey Partners, LLC increased its position in BCPC. The position peaked in Q2 2026 at 136.06K shares.

Which other funds hold BCPC?

Other major institutional holders of BCPC include Conestoga Capital Advisors, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.